LIST OF PARTIES Data Sample Clauses

LIST OF PARTIES Data exporter(s): 1. Name: The name of the Institution as specified in the Clinical Trial Agreement. Address: The address of the Institution as specified in the Clinical Trial Agreement. Contact person’s name, position and contact details: See notice section of the Clinical Trial Agreement. Activities relevant to the data transferred under these Clauses: See Clinical Trial Agreement. Signature and date: See signature of the Clinical Trial Agreement, which these SCCs relate to. Role (controller/processor): Controller Contact information to the Data Exporter(s) DPO: xxxxxxxxxxxxxxxxxxx Data importer(s): 1. Name: A. Janssen Research & Development, LLC Address: 000 Xxxxx 000 Xxxxx Xxxxxxx, Xxx Xxxxxx 00000 XXX Contact person’s name, position and contact details: See notice section of the Clinical Trial Agreement. Activities relevant to the data transferred under these Clauses: See Clinical Trial Agreement. Signature and date: See signature of the Clinical Trial Agreement, to which these SCCs relate. Role (controller/processor): Controller Contact information to the Data Importer(s) DPO: xxxxxxxxxxxxxxxxxxx B. DESCRIPTION OF TRANSFER Categories of data subjects whose personal data is transferred. The personal data transferred concern the following categories of data subjects: • Scientific and medical research subjects. • Scientific and medical research investigators and their staff, including, but not limited to, physicians and other health care professionals involved in administration of scientific research. • Other individuals involved in data exporter’s scientific and medical research (who may include consultants, representatives of service providers and business partners, government officials, and individuals who report adverse events and product quality complaints, among others). Categories of personal data transferred. The personal data transferred concern the following categories of data: • For scientific and medical research subjects, personal details may include key-coded information, other relevant identifiers (e.g., patient number); gender; age or age category (e.g., adolescent, adult, elderly) or date of birth (if necessary), associated health condition(s), medical history, and relevant family history. • For health care providers, or other points of contact, scientific and medical investigators and their staff, and other individuals involved in scientific and medical research, personal details may include contact information and other related information...
AutoNDA by SimpleDocs
LIST OF PARTIES Data exporter(s): 1. Name: The name of the Institution as specified in the Clinical Trial Agreement. Address: The address of the Institution as specified in the Clinical Trial Agreement. Contact person’s name, position and contact details: See notice section of the Clinical Trial Agreement. poriadok krajiny, v ktorej sídli zdravotnícke zariadenie, ako sa uvádza v Zmluve o klinickom skúšaní. (uveďte členský štát). D xxxxxx 00 Xxxxx xxxx a súdnej právomoci 1. Každý spor vyplývajúci z týchto doložiek majú riešiť súdy členského štátu EÚ.
LIST OF PARTIES Data exporter(s): 1. Name: The name of the Institution as specified in the Clinical Trial Agreement. Address: The address of the Institution as specified in the Clinical Trial Agreement. Contact person’s name, position and contact details: See notice section of the Clinical Trial Agreement. Activities relevant to the data transferred under these Clauses: See Clinical Trial Agreement. Signature and date: See signature of the Clinical Trial Agreement, which these SCCs relate to. budou řešit soudy členského státu EU. 2. Strany se dohodly, že se bude jednat o soudy země Zdravotnického zařízení uvedené ve Smlouvě o provádění klinického hodnocení, tedy o soudy České republiky.
LIST OF PARTIES Data exporter(s): 1. Name: The name of the Institution as specified in the Clinical Trial Agreement. Address: The address of the Institution as specified in the Clinical Trial Agreement. Contact person’s name, position and contact details: See notice section of the Clinical Trial Agreement. Activities relevant to the data transferred under these Clauses: See Clinical Trial Agreement. Signature and date: See signature of the Clinical Trial Agreement, which these SCCs relate to. Role (controller/processor): Controller Contact information to the Data Exporter(s) DPO: [enter info] Data importer(s): 1. Name: A. Janssen Research & Development, LLC Address: 920 Xxxxx 000 Xxxxx Xxxxxxx, Xxx Xxxxxx 00000 XXX Xontact person’s name, position and contact details: See notice section of the Clinical Trial Agreement. Activities relevant to the data transferred under these Clauses: See Clinical Trial Agreement. Signature and date: See signature of the Clinical Trial Agreement, to which these SCCs relate. Role (controller/processor): Controller této transparentnosti dosáhnout prostřednictvím jednoho dodatku. Pokud je to však nutné k zajištění dostatečné srozumitelnosti, měly by se použít samostatné dodatky. PŘÍLOHA I A.

Related to LIST OF PARTIES Data

  • LIST OF PARTIES Controller:

  • List of Plans Section 3(p) of the Disclosure Schedule contains an accurate and complete list of all employee benefit plans ("Employee Benefit Plans") within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended ("ERISA"), whether or not any Employee Benefit Plans are otherwise exempt from the provisions of ERISA, established, maintained or contributed to by OSMC (including all employers (whether or not incorporated) which by reason of common control are treated together with OSMC and/or the OSMC Stockholders as a single employer within the meaning of Section 414 of the Code) since September 2, 1974.

  • Certification Regarding Lobbying Applicable to Grants Subgrants, Cooperative Agreements, and Contracts Exceeding $100,000 in Federal Funds Submission of this certification is a prerequisite for making or entering into this transaction and is imposed by section 1352, Title 31, U.S. Code. This certification is a material representation of fact upon which reliance was placed when this transaction was made or entered into. Any person who fails to file the required certification shall be subject to a civil penalty of not less than $10,000 and not more than $100,000 for each such failure. The undersigned certifies, to the best of his or her knowledge and belief, that: (1) No Federal appropriated funds have been paid or will be paid by or on behalf of the undersigned, to any person for influencing or attempting to influence an officer or employee of any agency, a Member of Congress, an officer or employee of congress, or an employee of a Member of Congress in connection with the awarding of a Federal contract, the making of a Federal grant, the making of a Federal loan, the entering into a cooperative agreement, and the extension, continuation, renewal, amendment, or modification of a Federal contract, grant, loan, or cooperative agreement.

  • LIST OF SCHEDULES Schedule 1.1

  • Disclosure of Contractor Parties Litigation The Contractor shall require that all Contractor Parties, as appropriate, disclose to the Contractor, to the best of their knowledge, any Claims involving the Contractor Parties that might reasonably be expected to materially adversely affect their businesses, operations, assets, properties, financial stability, business prospects or ability to Perform fully under the Contract, no later than ten (10) Days after becoming aware or after they should have become aware of any such Claims. Disclosure shall be in writing.

  • Subproviders and Suppliers List Pursuant to requirements of 43 Texas Administrative Code §9.350 et seq., the Engineer must provide the State a list (Exhibit H-5/DBE or Exhibit H-6/HUB) of all Subproviders and suppliers that submitted quotes or proposals for subcontracts. This list shall include subproviders and suppliers names, addresses, telephone numbers, and type of work desired.

  • Data Return and Destruction of Data (a) Protecting PII from unauthorized access and disclosure is of the utmost importance to the EA, and Contractor agrees that it is prohibited from retaining PII or continued access to PII or any copy, summary or extract of PII, on any storage medium (including, without limitation, in secure data centers and/or cloud-based facilities) whatsoever beyond the period of providing Services to the EA, unless such retention is either expressly authorized for a prescribed period by the Service Agreement or other written agreement between the Parties, or expressly requested by the EA for purposes of facilitating the transfer of PII to the EA or expressly required by law. As applicable, upon expiration or termination of the Service Agreement, Contractor shall transfer PII, in a format agreed to by the Parties to the EA. (b) If applicable, once the transfer of PII has been accomplished in accordance with the EA’s written election to do so, Contractor agrees to return or destroy all PII when the purpose that necessitated its receipt by Contractor has been completed. Thereafter, with regard to all PII (including without limitation, all hard copies, archived copies, electronic versions, electronic imaging of hard copies) as well as any and all PII maintained on behalf of Contractor in a secure data center and/or cloud-based facilities that remain in the possession of Contractor or its Subcontractors, Contractor shall ensure that PII is securely deleted and/or destroyed in a manner that does not allow it to be retrieved or retrievable, read or reconstructed. Hard copy media must be shredded or destroyed such that PII cannot be read or otherwise reconstructed, and electronic media must be cleared, purged, or destroyed such that the PII cannot be retrieved. Only the destruction of paper PII, and not redaction, will satisfy the requirements for data destruction. Redaction is specifically excluded as a means of data destruction. (c) Contractor shall provide the EA with a written certification of the secure deletion and/or destruction of PII held by the Contractor or Subcontractors. (d) To the extent that Contractor and/or its subcontractors continue to be in possession of any de-identified data (i.e., data that has had all direct and indirect identifiers removed), they agree not to attempt to re-identify de-identified data and not to transfer de-identified data to any party.

  • LIST OF APPENDICES APPENDIX -------- General Information Relating to the Partnerships........................ A Table 1 Jurisdiction of Organization, Initial Investment by Limited Partners and Number of Limited Partners Table 2 Aggregate Merger Value Table 3 Merger Value Attributable to Partnership Interests of Limited Partners Table 4 Ownership Percentage and Merger Value Attributable to Nonmanaging General Partners Other Than Pioneer USA Table 5 Ownership Percentage and Merger Value Attributable to Pioneer USA Held in Its Capacities as General Partner, Nonmanaging General Partner and Limited Partner Table 6 Voting Percentage in Partnerships Beneficially Owned by Pioneer USA in Its Capacity as a Limited Partner Table 7 Historical Partnership Distributions Table 8 Annual Repurchase Prices and Aggregate Annual Repurchase Payments Table 9 Participation in Costs and Revenues of the Partnerships Table 10 Average Oil, Natural Gas Liquids and Gas Sales Prices and Production Costs Table 11 Proved Reserves Attributable to Pioneer USA, Other Nonmanaging General Partners and Limited Partners Table 12 Oil, Natural Gas Liquids and Gas Production Table 13 Productive Wellx xxx Developed Acreage Table 14 Recent Trades of Partnership Interests Summary Reserve Report of Willxxxxxx Xxxroleum Consultants, Inc. for the B Partnerships.......................................................... Form of Fairness Opinion of Robexx X. Xxxxxxx & Xo., Inc................

  • LIST OF SCHEDULES AND EXHIBITS Schedules

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!